ROBIN VANCLEAVE: Open Payments
NPI 1609099886 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 46 payments from 10 companies in 2025. Trend: 2023 $859 · 2024 $655 · 2025 $836
Food & beverage: $737Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 13 | $270 |
| Exeltis, USA Inc. | 8 | $181 |
| Organon LLC | 9 | $104 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $98 |
| Sumitomo Pharma America, Inc. | 4 | $63 |
| Hologic Sales and Service, LLC | 2 | $30 |
| MILLICENT US INC | 2 | $28 |
| CONMED Corporation | 1 | $27 |
| Radius Health, Inc. | 1 | $22 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: Veozah, TWIRLA, NEXPLANON, MYFEMBREE, SLYND, FEMLYV, AIRSEAL, Tymlos.
Industry payments across OK — which companies pay providers there.
